CELGENE ??? - 500 Beiträge pro Seite

[123Holg]

Was ist denn hier los ???

[honorar]

vom Handel ausgesetzt

[rotie1]

...im Videotext -98,46%

[honorar]

das war ein fehler im system, ist schon wieder berichtigt.
aktie ist weiter ausgesetzt, kein handel bisher heute

[bernie55]

Celgene halted for FDA vote
By Val Brickates Kennedy, MarketWatch
Last Update: 11:05 AM ET Sept. 14, 2005
E-mail it | Print | Alert | Reprint |

BOSTON (MarketWatch) - Shares of biotech group Celgene were halted early Wednesday pending the outcome of a regulatory meeting on the approvability of its drug Revlimid.

Celgene (CELG: news, chart, profile) shares were halted at $52.91 Wednesday morning.

An oncology drug advisory panel of the Food and Drug Administration is scheduled to meet this morning to vote on whether the company`s drug Revlimid should be recommended for approval.

Celgene is seeking to have Revlimid approved for the treatment of transfusion-dependant anemia due to certain myelodysplastic syndromes, a group of blood cell cancers.

Although the panel`s vote is not a final decision, the FDA traditionally abides by the recommendation of its expert panels. Celgene said a vote is expected by 12:30 p.m. Eastern time.

Celgene said that the FDA is scheduled to formally rule on whether to approve Revlimid by October 7.

The company already markets a version of thalidomide called Thalomid, for the treatment of leprosy, and Alkeran, a treatment for the cancer multiple myeloma. Celgene also receives royalties on the attention-deficit drugs Ritalin and Focalin, marketed by Novartis